Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11883373 Treatment of depression in certain patient populations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 13, 2023
0
Date of Patent
January 30, 2024
0
Patent Application Number
18333944
0
Patent Citations
‌
US Patent 11433067 Bupropion as a modulator of drug activity
0
‌
US Patent 11576877 Bupropion as modulator of drug activity
0
‌
US Patent 11576909 Bupropion as a modulator of drug activity
0
‌
US Patent 11590124 Bupropion as a modulator of drug activity
0
‌
US Patent 11596627 Bupropion as a modulator of drug activity
0
‌
US Patent 11617728 Bupropion as a modulator of drug activity
0
‌
US Patent 11617747 Bupropion as a modulator of drug activity
0
‌
US Patent 11628149 Bupropion as a modulator of drug activity
0
‌
US Patent 11660273 Dosage forms and methods for enantiomerically enriched or pure bupropion
0
‌
US Patent 11660274 Dosage forms and methods for enantiomerically enriched or pure bupropion
0
•••
Patent Citations Received
‌
US Patent 11986444 Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
0
‌
US Patent 12109178 Bupropion as a modulator of drug activity
0
‌
US Patent 11969421 Bupropion as a modulator of drug activity
0
Patent Inventor Names
Herriot Tabuteau
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11883373
0
Patent Primary Examiner
‌
Kevin E. Weddington
0
CPC Code
‌
A61P 25/24
0
‌
A61K 31/485
0
‌
A61K 31/137
0

Find more entities like US Patent 11883373 Treatment of depression in certain patient populations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo